Dali Pharmaceuticalco.,Ltd

603963

CNE100002VL4

Pharmaceuticals

End-of-day quote Shanghai S.E. Other stock markets 18:00:00 2024-07-02 EDT			5-day change	1st Jan Change
2.75 ^CNY	+4.96%		+4.96%	-76.85%

05-13	Dali Pharmaceuticalco.,Ltd(SHSE:603963) dropped from Shanghai Stock Exchange A Share Index	CI
05-13	Dali Pharmaceuticalco.,Ltd(SHSE:603963) dropped from Shanghai Stock Exchange Composite Index	CI

Dali Pharmaceuticalco.,Ltd(SHSE:603963) dropped from Shanghai Stock Exchange A Share Index

May 12, 2024

Dali Pharmaceutical Co., Ltd has been dropped from Shanghai Stock Exchange A Share Index

Latest news about Dali Pharmaceuticalco.,Ltd

Dali Pharmaceuticalco.,Ltd(SHSE:603963) dropped from Shanghai Stock Exchange A Share Index	05-12	CI
Dali Pharmaceuticalco.,Ltd(SHSE:603963) dropped from Shanghai Stock Exchange Composite Index	05-12	CI
Dali Pharmaceuticalco.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	04-25	CI
Dali Pharmaceuticalco.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	04-25	CI
China stocks track Asian markets lower on rate concerns	04-12	RE
China stocks rise as commodities shine; Hong Kong snaps winning streak	04-11	RE
China stocks edge lower as yuan eases, property sector in focus	03-26	RE
China, Hong Kong stocks up as yuan rebounds	03-25	RE
China stocks fall on weaker yuan, outflows	03-22	RE
Dali Pharmaceuticalco.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-09	CI
Dali Pharmaceuticalco.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-28	CI
Dali Pharmaceuticalco.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-27	CI
Dali Pharmaceuticalco.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-27	CI
Dali Pharmaceuticalco.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-27	CI
Dali Pharmaceuticalco.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-25	CI
Dali Pharmaceuticalco.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-27	CI
China shares fall as high valuations drain out power from EV stocks	22-03-01	RE
Dali Pharmaceutical Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-28	CI
Dali Pharmaceutical Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-24	CI
Dali Pharmaceutical Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2021	21-04-21	CI
Dali Pharmaceutical Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2020	20-10-29	CI
Certain A Shares of Dali Pharmaceutical Co., Ltd are subject to a Lock-Up Agreement Ending on 22-SEP-2020.	20-09-21	CI
Dali Pharmaceutical Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2020	20-08-18	CI
Dali Pharmaceutical Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2019	20-04-22	CI
Dali Pharmaceutical Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2019	19-10-22	CI

Chart Dali Pharmaceuticalco.,Ltd

Duration

Period

More charts

Dali Pharmaceutical Co Ltd is a China-based company principally involved in the production and sales of Chinese and western medicine injections. The Companyâs main products include Xingnaojing injections and Shenmai injections. The other products include astragalus injections and mycorrhizal injections. Through its subsidiaries, the Company is also involved in the lease of offices and factory buildings, as well as the investment of equity.

Sector

Pharmaceuticals

Calendar

2024-07-12 - Extraordinary Shareholders Meeting

More about the company

Income Statement Evolution

More financial data

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
DALI PHARMACEUTICALCO.,LTD	-76.85%	83.12M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+23.63%	44.09B
OTSUKA HOLDINGS CO., LTD.	+30.04%	23.18B
SANDOZ GROUP AG	+21.51%	15.66B
CIPLA LIMITED	+18.43%	14.35B
ZYDUS LIFESCIENCES LIMITED	+62.41%	13.2B
THE MEDICINES COMPANY	-0.05%	6.79B
ONO PHARMACEUTICAL CO., LTD.	-11.78%	6.45B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+14.11%	5.63B